CJC-1295 (no DAC), Ipamorelin, and GHRP-2 is a research peptide blend formulated to investigate synergistic mechanisms of growth hormone release through dual receptor activation. CJC-1295 (Mod GRF 1–29) binds to GHRH receptors, stimulating cAMP/PKA signaling in pituitary somatotrophs, while Ipamorelin and GHRP-2 act as ghrelin receptor (GHS-R1a) agonists engaging Gq/11-mediated calcium mobilization. This combination is used in endocrine research examining GH pulsatility, peptide receptor synergy, and hypothalamic–pituitary signaling modulation.
For research use only. Not for human consumption.
References:
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Kojima M et al., Nature, 1999 402(6762):656–660

Adipotide (FTPP) 10mg 





Reviews
There are no reviews yet.